Peer Review History
| Original SubmissionFebruary 15, 2022 |
|---|
|
PONE-D-22-04659Static posturography as a novel measure of the effects of aging on postural control in dogsPLOS ONE Dear Dr. Olby, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The method presented in your study is interesting, novel, and potentially very useful to the veterinary community. Thank you for submitting it to PLOS ONE. The reviewers liked your manuscript and the overall approach of the study. One reviewer requested additional attention to the statistical analysis---please be sure to address those questions. Please submit your revised manuscript by May 08 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Richard Evans Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In your Methods section, please provide additional details regarding participant consent from the owners of the animals. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal). If the need for consent was waived by the ethics committee, please include this information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Static posturography as a novel measure of the effects of aging on postural control in dogs. This is a reasonably well written paper that generated a large volume of data. Interpretation of that data is challenging because the findings are not always uniform. The authors discussion of limitations and final conclusions are fair, but some clarifications are needed. My biggest obstacles with this paper were 1) interpreting how they selected data, 2) the shear volume of acryonyms and data presented will challenge many readers, 3) ICC is calculated on averaged data, not raw data and 4) the number of statistical evaluations performed. 67 “…cheaper…” this is brand dependent and certain brands are at least twice the cost of a force platform set up. Please remove. 91/442 Why 0.75 as a cutoff, why not the 0.7 cutoff as supported by this cited literature. Also, since time is a continuous variable, why not evaluate the data to see if there is change in COP associated with adjusted age. Regardless, at least provide rationale for making this cutoff. It may be as easy as this was exploratory research and other options beyond a 0.75 cutoff should be investigated. 98/409 Was this the extent of the morphometric measurements? Why dog height and not length and width? Not investigating if other morphometric measurements influence COP is a potential limitation of the study. 131 Is this the definition of a valid trial? 136 Do you mean 70 consecutive frames, from 7 trials? I’m unsure of what you did here given your previous description of inclusion criteria; were some dogs studied even though they didn’t achieve the “inclusion criteria”. Were these frames and trials randomly selected? In the discussion, you mention you averaged all of this data. Please clarify how you handled this data, it is unclear to me and I would not be able to reproduce this experiment. From the review of your data, it seems that you began with 5360 data points, from this you selected (random?)(and averaged?) 70 data points from 7 of 10 (random?) valid trials leaving your with 7 data points for each dog, then this was averaged. Is this what was statistically evaluated? Post hoc handling of your data needs to be clear and logical. 137 On line 129, you stated, “for inclusion, at least 10 valid trials were required”. Clarify how you could have data if “fewer than 7 individual trials were available”. 222 It seems this should be calculated on the raw data, not averaged data that is a subset of the raw data. Please defend this methodology or perform on raw data. Tables Often, the r^2 are significant, but quite small. Please address the importance of these findings. Reviewer #2: First, I will make some background comments and then suggest specific changes to the manuscript. Do not feel obliged to respond to the background comments, but you can if you want to. I provided them to put my specific recommendations in context. Background comments I approached this paper as someone who might use this method to assess the efficacy of a therapy using a clinical trial and COP measures. What would I need to know from your paper to help me design and analyze my study? 1. I would like to see summary statistics (e.g., means, standard deviations, etc.) of the COP outcomes, for each group. That way, I could put my results in the context of your results, albeit informally. If my numbers were very different from yours, I might have a problem with my study or population. 2. I would like to know the COP outcomes with the lowest relative variation, assessed with their coefficients of variations. That way, I can directly compare variables. This is a simple, standard approach. 3. I would like to know which variables and combination of variables best distinguish between group A and group B dogs. That way, I can pick a couple of primary variables before my study begins. Finding such variables is commonly done with an ROC curve analysis. I understand that lines 508+ attempts to suggest variables, but correlations don't tell me what I want to know. An area under the ROC curve does. This manuscript mainly reported results from regressions. Regressions have four assumptions: independence, linearity, conditional normality, and homoscedasticity. It's not clear that the investigators checked any of these in the analysis. Note that the normality of POS outcomes themselves is not one of the linear regression assumptions. The manuscript primarily reports three statistics: the adjusted r-square, the standardized beta, and p-values. The adjusted r-squares and the standardized beta aren't very helpful--even the authors don't use them to describe the results in the papers. They are simply put in tables and left there. The authors mostly use statistical significance to assess their results. The problem is that there are over 221 p-values assessed for statistical significance in this report. That means we expect to see more than 11 statistically significant results that are false discoveries. But we don't know which are false discoveries. (221x0.05 is about 11) So when the authors rely on statistical significance to make claims such as line 407 and line 428, we don't know if they are among the 11 false-positive statements. Another problem with the p-values is that they depend on sample size so that a weak effect can become statistically significant with a larger sample size. For example, height has a minimal effect (r-square) on COP variables. Frankly, I'd ignore height in this analysis of COP data. But because your sample size is large enough to make height statistically significant, it appears to have more importance than it deserves. Also, a particular COP variable might have the same effect size in both groups, but because group B has a smaller sample size than group A, there might be statistical significance in A but not B. So, the disparity in sample sizes can affect group comparison based on p-values Finally, I challenge you to remove the lines and colors in figure 4 and see if your eye can detect changes in postural sway with fractional age. The problem is that the human eye focuses on the lines but not really on the confidence intervals. I could draw a legitimate line within the intervals on the group B side that angles downwards, showing that postural sway decreases with fractional age. In fact, you should have statistically compared the slopes of the A and B sides of those plots. If those slopes are different, then age might affect sway. Specific suggested changes--major points 1. Please consider reporting my additional analyses noted in points 1 to 3 above. Before suggesting those analyses, I tried them on your data. It took only an hour, and I was able to discount height as a factor--its slope is tiny. I also found that two COP variables differentiate group A and group B well, with AUC=0.8. (I used a stepwise logistic regression). 2. I'm not sure how you can claim that older dogs have worse sway because (1) groups A and B were never directly compared with any statistical test, and (2) group B is confounded with lame dogs. In particular, I'm not sure the statements in lines 435+ are correct. It looks to me like a couple of outlying dogs are driving your statements. Please compare the groups directly on COP variables and the regression slopes in figure 4, and explain how you untangle the lameness (pain, etc.) issues. 4. Discuss the adjusted r-square and standardized betas in the discussion section or remove them. 6. If you wish to keep the regressions, then check the regression assumptions for each regression. Minor points 1. I believe you used multivariate regression but sometimes called it multiple regression, which is different. Please fix the terminology. 2. Put Dr. Lascelles name on one line. The "B." is at the end of the previous line. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Static posturography as a novel measure of the effects of aging on postural control in dogs PONE-D-22-04659R1 Dear Dr. Olby, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Richard Evans Academic Editor PLOS ONE Additional Editor Comments (optional): Thank you for your timely revision of the manuscript. We know it was a lot of work, and we appreciate your professionalism. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-22-04659R1 Static posturography as a novel measure of the effects of aging on postural control in dogs Dear Dr. Olby: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Richard Evans Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .